Design,synthesis and on-target antibacterial activity of novel small molecule FtsZ inhibitors

来源 :全国药物化学学术会议暨第四届中英药物化学学术会议 | 被引量 : 0次 | 上传用户：zzy101

【摘要】

：

3-Alkyloxybenzamide derivatives as FtsZ inhibitors exhibited greatly improved on-target activity and antibacterial activity against penicillin-susceptible and-resistant S.aureus,and methicillin-resist

【作者】

：

Changde Wang Yunkun Qi Siti Ma Shutao Ma

【机构】

：

Department of Medicinal Chemistry,School of Pharmaceutical Sciences,Shandong University,44,West Cult

【出处】

：

全国药物化学学术会议暨第四届中英药物化学学术会议

【发表日期】

：

2013年11期

【关键词】

：

Arylalkoxybenzamide FtsZ inhibitors Synthesis On-target activity Bacterial activ

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

CypA/p53/G3BP1信号转导新通路的确证及其在抗肿瘤联合用药中的应用

会议

Structure-based design,synthesis,and evaluation of novel PI3K/mTOR dual inhibitors

会议

海洋吡咯类生物碱Ningalin B类似物的设计合

会议

多药耐药MDR逆转剂NingalinB类似物

Extracellular Signal-regulated Kinases(ERK)Inhibitors from Aristolochia yunnanensis

Six new sesquiterpenoids,aristoyunnolins A?F(1?6),an artifact of isolation [7-O-ethyl madolin W(7)],and 12 known analogues were isolated from stems of Aristolochia yunnanensis.The structures were dete

会议

KERK InhibitorsAristolochia yunnanensissesquiterpenoidsstructure elucidation

Design,Synthesis and Biological Evaluation of 6-Arylindeno[1,2-c]isoquinoline Derivatives as Anti-br

会议

靶向H2S气体信号通路关键酶的新型小分子调控剂的发现

越来越多的研究表明，内源性的H2S在很多人体器官和组织发挥重要的生理功能，包括心血管、神经、消化、血液、内分泌和免疫等多种人体机能系统.在结肠癌、唐氏综合症、低血压、高血压和胰腺炎等很多病理条件下，内源性H2S含量都发现有异常变化.Cystathionine β-synthase(CBS)和cystathionine γ-lyase(CSE)是产生H2S的关键酶，因此寻找这两个酶的抑制剂或激活剂被

会议

H2S酶抑制剂高通量抑制剂筛选疾病药物先导物

Discovery of Highly Specific Kinase Inhibitors via Compound Centric Kinome-wide Profiling Approach

Kinases play pivotal role play pivotal roles in virtually all aspects of cellular physiology1.Potent and selective kinase inhibitors are highly desirable,both as tool compounds for dissecting complex

会议

黄病毒属病毒蛋白酶抑制剂的发现

会议

Discovery of novel pyrimidone inhibitors of HIV-1 integrase

Raltegravir is the first approved integrase inhibitor for the treatment of HIV.The rapid mutation of the virus has led to chemo-resistant strains and there is a medical need to develop new drugs to ov

会议

HIV-1Integrase inhibitorsPyrimidone analogues

Discovery and development of multi-target anti-fibrosis agents

Fibrosis is a pathological process in damaged tissues or organs where fibroblasts are activated to produce and deposit excess extracellular matrix.Accumulating evidence indicate that complicated proce

会议

Design,synthesis and on-target antibacterial activity of novel small molecule FtsZ inhibitors

其他学术论文